Michael A. Jenike - McLean Hospital - Harvard University

5
1984-1987 American Psychiatric Association Task Force on Treatment
of Psychiatric Disorders (Organic Mental Syndromes)
1985-1989 Food and Drug Administration Peripheral and Central
Nervous System Drugs Advisory Committee
1988- Consultant to Health Care Financing Administration on
topic of psychopharmacology in nursing homes
1989- Member, Scientific Advisory Board, Obsessive
Compulsive Disorders Foundation
1989- Ad Hoc Reviewer for Veterans Administration Research
Proposals
1989- Member, DSM-IV Committee on Obsessive-Compulsive
Disorders
1989- Ad Hoc Reviewer, National Institute of Mental Health
Treatment Development and Assessment Research Review
Committee, Subcommittee on Psychopharmacological,
Biological, and Physical Treatments
1990- Consultant, American Medical Association, Division of
Drugs and Toxicology, Drug Evaluations
1992 Consultant to American Psychiatric Association's Practice
Guidelines Panel on Major Depression
1992 Prepared report on: "Obsessive-compulsive disorder:
Efficacy of specific treatments as assessed by controlled
trials" for the United States Department of Health and
Human Services Public Health Service as part of the Report
of the National Advisory Mental Health Council titled
"Health Care Reform for Americans with Severe Mental
Illnesses."
1992 Work Group on Obsessive-Compulsive Disorders.
International Algorithm Project, Washington, D.C.
1994 Member, Diagnostic and Therapeutic Technology
Assessment (DATTA) Group. American Medical
Association.
1994- Scientific Advisory Board, Tourette Society of America.